USANA (USNA) Director Nixon J. Scott Converts 1,632 RSUs

What Happened
Nixon J. Scott, a director of USANA Health Sciences (USNA), had 1,632 restricted stock units (RSUs) convert to common shares on July 23, 2026. The Form 4 reports an acquisition/conversion of 1,632 shares (derivative exercise/conversion) and an immediate disposition of 1,632 shares at $0.00. No cash proceeds are reported; this was a vesting/conversion event rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-07-23. Filing date: 2026-07-27 (filed within the normal reporting window).
• Reported transactions: 1,632 shares acquired via conversion of a derivative (code M) and 1,632 shares disposed at $0.00.
• Price/Value: Acquisition price listed as N/A; disposition price listed as $0.00 (no cash proceeds shown).
• Shares owned after transaction: Not specified in the provided filing.
• Footnotes:
  • F1: Each RSU represents a contingent right to receive one share of USNA common stock.
  • F2: The RSUs vest 25% on Jul 23, 2026, Oct 22, 2026, Jan 21, 2027, and Apr 22, 2027.
• Filing timeliness: The report was filed on 2026-07-27 for a 2026-07-23 transaction (filed within the typical two-business-day Form 4 window).

Context

• Code M indicates exercise or conversion of a derivative — here, RSUs vested and converted into shares. The immediate disposition at $0.00 is commonly used in filings when shares are withheld or net-settled for tax withholding or administrative purposes; the Form 4 itself does not spell out the reason.
• This transaction reflects vesting and conversion of compensation awards rather than an active buy or sell that signals a change in the insider’s market view.